<DOC>
	<DOC>NCT00093977</DOC>
	<brief_summary>The purpose of this study is to determine whether darbepoetin alfa manufactured by the current "roller bottle" technology and darbepoetin alfa manufactured by a serum free process have a comparable safety profile.</brief_summary>
	<brief_title>Study to Assess Darbepoetin Alfa in Subjects With Chronic Kidney Disease</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency, Chronic</mesh_term>
	<mesh_term>Darbepoetin alfa</mesh_term>
	<criteria>Currently diagnosed with Chronic Kidney Disease, either receiving or not receiving dialysis Anemic Currently on erythropoietic therapy Controlled hypertension Clinically stable</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>Chronic Kidney Disease</keyword>
	<keyword>Dialysis</keyword>
	<keyword>Anemia</keyword>
	<keyword>Nephrology</keyword>
</DOC>